Aurora Cannabis Operating Income 2017-2024 | ACB
Aurora Cannabis Annual Operating Income (Millions of US $) |
|
---|---|
2024 | $-34 |
2022 | $-183 |
2021 | $-221 |
2020 | $-366 |
2019 | $-237 |
2018 | $-83 |
2017 | $-8 |
2017 | $-20 |
2016 | $1 |
Aurora Cannabis Quarterly Operating Income (Millions of US $) |
|
---|---|
2024-06-30 | $1 |
2024-03-31 | $3 |
2023-12-31 | $-18 |
2023-09-30 | $-8 |
2023-06-30 | $-12 |
2022-12-31 | $-53 |
2022-09-30 | $-41 |
2022-03-31 | $40 |
2021-12-31 | $-44 |
2021-09-30 | $-31 |
2021-03-31 | $44 |
2020-12-31 | $-36 |
2020-09-30 | $-32 |
2020-03-31 | $56 |
2019-12-31 | $-91 |
2019-09-30 | $-59 |
2019-03-31 | $49 |
2018-12-31 | $-61 |
2018-09-30 | $-86 |
2018-06-30 | |
2018-03-31 | $-24 |
2017-12-31 | $-12 |
2017-09-30 | $-1 |
2017-06-30 | |
2017-03-31 | $4 |
2016-12-31 | $3 |
2016-09-30 | $2 |
2016-06-30 | $1 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.319B | $0.200B |
Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $195.617B | 25.27 |
Stryker (SYK) | United States | $137.290B | 32.08 |
Boston Scientific (BSX) | United States | $122.743B | 37.38 |
Medtronic (MDT) | Ireland | $114.552B | 17.05 |
EssilorLuxottica (ESLOY) | France | $108.842B | 0.00 |
Haleon (HLN) | United Kingdom | $48.651B | 35.57 |
Lonza Group Ag (LZAGY) | Switzerland | $46.030B | 0.00 |
ResMed (RMD) | United States | $35.117B | 30.92 |
Koninklijke Philips (PHG) | Netherlands | $30.774B | 23.39 |
Terumo (TRUMY) | Japan | $28.517B | 40.27 |
Zimmer Biomet Holdings (ZBH) | United States | $22.039B | 13.87 |
Baxter (BAX) | United States | $19.851B | 13.46 |
Insulet (PODD) | United States | $16.269B | 68.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.605B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.247B | 30.63 |
Demant (WILYY) | Denmark | $8.667B | 0.00 |
BellRing Brands (BRBR) | United States | $7.898B | 33.39 |
Lantheus Holdings (LNTH) | United States | $7.454B | 17.89 |
ICU Medical (ICUI) | United States | $4.261B | 40.67 |
Haemonetics (HAE) | United States | $4.084B | 20.20 |
TG Therapeutics (TGTX) | United States | $3.689B | 39.07 |
Neogen (NEOG) | United States | $3.599B | 37.75 |
Prestige Consumer Healthcare (PBH) | United States | $3.534B | 17.61 |
GN Store Nord (GNNDY) | Denmark | $3.509B | 21.14 |
Perrigo (PRGO) | Ireland | $3.499B | 11.06 |
Envista Holdings (NVST) | United States | $3.398B | 18.13 |
QuidelOrtho (QDEL) | United States | $3.063B | 19.30 |
Agios Pharmaceuticals (AGIO) | United States | $2.595B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $2.226B | 37.36 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.124B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $2.061B | 54.92 |
Warby Parker (WRBY) | United States | $1.614B | 0.00 |
AdaptHealth (AHCO) | United States | $1.497B | 10.81 |
InMode (INMD) | Israel | $1.464B | 9.32 |
AtriCure (ATRC) | United States | $1.372B | 0.00 |
Owens & Minor (OMI) | United States | $1.247B | 9.63 |
Verano Holdings (VRNOF) | United States | $1.184B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.123B | 0.00 |
Evolus (EOLS) | United States | $1.006B | 0.00 |
PetIQ (PETQ) | United States | $0.919B | 23.30 |
Phibro Animal Health (PAHC) | United States | $0.894B | 18.55 |
National Vision Holdings (EYE) | United States | $0.867B | 27.55 |
Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 116.64 |
Quanterix (QTRX) | United States | $0.489B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.488B | 14.72 |
Jin Medical (ZJYL) | China | $0.439B | 0.00 |
ZimVie (ZIMV) | United States | $0.435B | 40.41 |
Valneva SE (VALN) | France | $0.432B | 0.00 |
Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.389B | 0.00 |
Cerus (CERS) | United States | $0.324B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.324B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 8.25 |
Biote (BTMD) | United States | $0.307B | 14.18 |
Viemed Healthcare (VMD) | United States | $0.283B | 30.38 |
Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
Zynex (ZYXI) | United States | $0.257B | 45.00 |
Utah Medical Products (UTMD) | United States | $0.232B | 15.41 |
Omeros (OMER) | United States | $0.227B | 0.00 |
MacroGenics (MGNX) | United States | $0.200B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.194B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.191B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 67.33 |
FitLife Brands (FTLF) | United States | $0.153B | 20.64 |
Brainsway (BWAY) | Israel | $0.135B | 161.40 |
TriSalus Life Sciences (TLSI) | United States | $0.130B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.121B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.114B | 0.00 |
Veru (VERU) | United States | $0.113B | 0.00 |
Fonar (FONR) | United States | $0.111B | 11.44 |
Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.80 |
InterCure (INCR) | Israel | $0.087B | 14.62 |
Zevia PBC (ZVIA) | United States | $0.083B | 0.00 |
Cytosorbents (CTSO) | United States | $0.082B | 0.00 |
Modular Medical (MODD) | United States | $0.074B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
Safety Shot (SHOT) | United States | $0.071B | 0.00 |
MariMed (MRMD) | United States | $0.065B | 0.00 |
Exagen (XGN) | United States | $0.055B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.051B | 3.35 |
Apyx Medical (APYX) | United States | $0.042B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.007B | 0.00 |
Agape ATP (ATPC) | $0.007B | 0.00 | |
Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 21.30 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |